Skip to main content

TGA provisionally approves AstraZeneca's combination therapy (tixagevimab and cilgavimab, EVUSHELD) - for treatment and pre-exposure prevention (prophylaxis) of COVID-19

Last updated

Help us improve the Therapeutic Goods Administration site